Limk2 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Limk2 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
LIMK2 (LIM Domain Kinase 2) encodes a serine/threonine kinase that, like LIMK1, regulates actin cytoskeleton dynamics through phosphorylation of cofilin family proteins. While LIMK1 and LIMK2 share structural similarities, they have distinct expression patterns and functions. LIMK2 is particularly important in muscle development, brain development, and has been implicated in various neurodegenerative diseases [1](https://pubmed.ncbi.nlm.nih.gov/10442087/).
Function
Enzymatic Activity
LIMK2 is a serine/threonine kinase that:
Phosphorylates and inactivates cofilin-1 and cofilin-2
Regulates actin filament turnover
Promotes actin stress fiber formation
Protein Structure
LIMK2 contains:
N-terminal LIM domains (2): Zinc-binding motifs for protein interactions
PDZ domain: Postsynaptic density interactions
C-terminal kinase domain: Catalytic activity
Isoforms
LIMK2 has multiple isoforms:
LIMK2a: Full-length isoform with complete domain structure
LIMK2b: Truncated isoform missing some N-terminal regions
Disease Associations
Alzheimer's Disease
LIMK2 involvement in AD:
Cofilin regulation: LIMK2-mediated cofilin phosphorylation is altered in AD brain [2](https://doi.org/10.1016/j.nbd.2019.104669)
Actin cytoskeleton: Disrupted cytoskeletal dynamics contribute to synaptic loss
[Tau](/proteins/tau) pathology: Interaction with tau phosphorylation pathways
Parkinson's Disease
In PD:
Dopaminergic [neurons](/entities/neurons): LIMK2 regulates cytoskeletal dynamics in dopaminergic neurons
[Alpha-synuclein](/proteins/alpha-synuclein): Altered expression in response to [alpha-synuclein](/mechanisms/alpha-synuclein) aggregation
Mitochondrial function: LIMK2 implicated in mitochondrial dynamics
Huntington's Disease
LIMK2 has been specifically implicated in HD:
Mutant [huntingtin](/proteins/huntingtin): LIMK2 is a substrate for mutant huntingtin
LIMK2 represents a potential therapeutic target for neurodegenerative diseases:
Drug Development
LIMK inhibitors: Small molecule inhibitors of LIMK activity are under development for various indications
Actin remodeling: Targeting LIMK2 may help restore cytoskeletal function in neurodegeneration
Synaptic protection: LIMK2 modulation may protect synaptic structure and function
Research Directions
Biomarker potential: LIMK2 expression levels may serve as biomarkers for disease progression
Gene therapy: Vector-mediated LIMK2 expression or inhibition approaches being explored
Key Publications
[Ikebe C, et al. (1998) - LIMK2: a serine/threonine kinase](https://pubmed.ncbi.nlm.nih.gov/10442087/)
[Huang TY, et al. (2019) - Cofilin in neurodegeneration](https://doi.org/10.1016/j.nbd.2019.104669)
[Saitoh M, et al. (2006) - LIMK2 in cell motility](https://pubmed.ncbi.nlm.nih.gov/16525033/)
Cross-Links
[LIMK2 Protein](/proteins/limk2) - Protein product
[LIMK1](/genes/limk1) - Related kinase
[Cofilin](/proteins/cofilin) - Substrate
See Also
[LIM Kinase 2](/proteins/limk2) - Protein product
[LIMK1](/genes/limk1) - Related kinase
[Actin Cytoskeleton Dynamics](/mechanisms/actin-cytoskeleton-dynamics) - Related mechanism
[Cofilin](/proteins/cofilin) - Primary substrate
External Links
[LIMK2 Gene at NCBI](https://www.ncbi.nlm.nih.gov/gene/3985) - Gene database entry
[LIMK2 at UniProt](https://www.uniprot.org/uniprot/P53671) - Protein database entry
[PubMed Literature](https://pubmed.ncbi.nlm.nih.gov/?term=LIMK2) - Literature search
Background
The study of Limk2 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
References
[Ikebe C, et al., (1998) - LIMK2: a serine/threonine kinase (1998)](https://pubmed.ncbi.nlm.nih.gov/10442087/)
[Huang TY, et al., (2019) - Cofilin in neurodegeneration (2019)](https://doi.org/10.1016/j.nbd.2019.104669)
[Saitoh M, et al., (2006) - LIMK2 in cell motility (2006)](https://pubmed.ncbi.nlm.nih.gov/16525033/)